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1. Introduction 
For a paediatrician, children with bronchitis are part of the daily work. Infections of the 
respiratory system are the most common reason for children presenting at the doctor´s 
practice. Almost all infants and younger school children become sick several times a year 
with a bronchitis. In most cases with the beginning of day nursery or nursery school there is 
an abrupt accumulation and many parents have the feeling that their child is permanently 
ill. That bronchitis occurs much more frequently in winter than in summer, as everyone 
knows from personal experience. The cold air outside and the dry heated air indoors, 
increases the vulnerability of the mucosa for pathogens. Whether the clinical course of a 
bronchitis is uncomplicated or associated with a bronchial obstruction, is partly caused by 
the genetic predisposition of the child. Depending on family history of bronchial asthma 
and allergies, the risk may be increased many times over. The health damage due to 
exposure to tobacco smoke is a major point which should not be underestimated. 
The following pages describe in the form of a brief overview symptoms and signs of 
bronchitis in children. The different types and stages of bronchitis are shown. The most 
common viruses that cause bronchitis are described, in particular the respiratory syncytial 
virus. One chapter deals with bronchopulmonary dysplasia, an important risk factor for 
bronchitis in children. Furthermore, some important differential diagnoses are presented, 
which can become manifest with the typical symptoms of a bronchitis. The laboratory 
diagnosis with the aim of differentiating between viral and bacterial bronchitis is discussed. 
Finally, therapeutic options are mentioned. 
2. Signs and symptoms of bronchitis in children 
2.1 Cough 
The main symptom of bronchitis is a cough. At the beginning of the disease it tends to be 
dry and unproductive. With increasing production of secretion the mucus becomes less 
viscous, which makes coughing more effective. Some children have such severe coughing 
attacks that vomiting can be induced. An adequate supply of volume and inhalation therapy 
with 0.9% NaCl can help to make the mucus more fluid, enabling it to be brought up more 
easily by coughing. There are medications, usually in the form of so-called cough syrups, 
which will also assist mucolytic activity. After regression of an acute bronchitis, an 
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unpleasant dry cough can still remain for several days or weeks. This is caused by a 
transient hyperreactivity of the bronchial system due to the infection-induced inflammation. 
2.2 Tachypnoea and dyspnoea 
If secreted mucus, an oedema of the bronchial mucosa or a spasm of the bronchial 
musculature induce bronchial obstruction, tachypnoea and dyspnoea may belong to the 
acute disorders. Typical clinical signs for dyspnoea are movement of the nostrils, inter- or 
subcostal retractions, use of accessory respiratory muscles, an upright upper body position, 
and in the auscultation wheezing and sometimes also rales. In this situation inhalation 
therapy with bronchodilatatory agents and the systemic administration of steroids may be 
helpful. Because the expiration is more difficult that the inspiration, an emphysema may be 
formed due to air trapping. Children with respiratory distress may become anxious and 
excited, which makes the situation worse. The excitement and anxiety of the parents may 
also be transferred to the child. In the case of severe respiratory distress, the oxygen 
saturation in the blood may decrease critically, making oxygen substitution necessary. 
Measurement of vital parameters and blood gas analyses are standard procedures. The 
suctioning of secretions and mucus, or the application of respiratory supportive procedures, 
such as CPAP or intubation and ventilation, should be made immediately possible. 
2.3 Pain 
Pain in the context of bronchitis can be caused by an inflammatory involvement of the 
trachea or pleura. In the case of retrosternal pain during coughing, a tracheitis is most 
probable. Respiratory-dependent, especially in deep inspiration increasing pain, which is 
localized more laterally in one or both sides of the chest, makes a pleuritis more probable. 
Especially the dry chafing of inflamed visceral pleura and parietal pleura against each other 
is very painful. If the child develops shallow breathing to avoid the pain, an insufficient 
ventilation of the lung may result with the increased risk of a secondary bacterial infection. 
For this reason, an appropriate analgesia is strongly recommended. 
2.4 Fever 
Fever is a general clinical sign, which may occur in any infection, including one of the 
respiratory system. The increase of body temperature is a non-specific symptom and can 
range from low-grade fever up to hyperpyrexia with acute physical stress for the child. In 
the case of an infection of the upper respiratory tract, additionally clinical signs (in addition 
to the cough, tachydyspnea, pain and fever) are sniffing (rhinitis), a sore throat (pharyngitis) 
and earache (otitis media). Furthermore, swollen and aching cervical lymph nodes are a 
common local response to the inflammation process. 
3. Different types of bronchitis in children 
3.1 Acute, complicated, chronic, recurrent 
The average duration of an acute bronchitis is about 1 week with the range from ½ week up 
to 2 weeks. Afterwards a nervous cough may remain for several days or a few weeks. The 
acute bronchitis has a very high rate of complete recovery; the prognosis is very good. An 
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exception is an acute bronchitis caused by adenovirus; in this case complications in the 
clinical course or a chronification of the bronchitis are described. 
If the symptoms and signs of an acute bronchitis persist for 4 – 6 weeks, we call it compli-
cated bronchitis. If an acute bronchitis is followed by another one, they can be taken for a 
complicated bronchitis by mistake. Approximately 20% of acute bronchitis has a complica-
ted course. One possible complication is the secondary bacterial superinfection of a primary 
viral infection. In this case the child needs to be treated with antibiotics. Another possible 
complication is the transition from bronchitis into bronchopneumonia. In many cases this is 
detectable by pulmonary auscultation, but to confirm the diagnosis, a chest X-ray is 
necessary. A primary bacterial bronchitis usually presents clinically as a complicated 
bronchitis. 
Signs and symptoms of a bronchitis persisting for more than 3 months are called chronic 
bronchitis. 
If children repeat lots of acute bronchitis over months, it is called recurrent bronchitis. 
Mainly children in day nursery or nursery school are affected quite often, because the risk of 
infection is particularly high there. In the cold seasons bronchitis occurs more frequently 
compared to the warm seasons. 
3.2 Non-obstructive or obstructive 
Bronchitis can be associated more or less with bronchial obstruction. The risk of an 
obstruction depends on the lumen of the inflamed bronchus; the smaller the lumen, the 
more likely is a clinically relevant obstruction. For this reason, the terms “obstructive 
bronchitis” and “bronchiolitis” were sometimes used as synonyms. Bronchial obstruction 
can be caused by the following pathophysiological alterations:  
1. The smooth muscles of the bronchus get contracted, which can lead to an acute 
shortness of breath.  
2. The mucosa of the respiratory epithelium is swollen due to the inflammation, which 
narrows the bronchial lumen. 
3. The increased production of mucus clogs the lumen as well. Furthermore, due to the 
inflammation in the respiratory epithelium, the function of the cilia is reduced, and 
mucus cannot be transported adequately. 
Auscultation of the lung shows wheezing. A so-called silent lung is typical for a severe 
bronchial obstruction with air trapping and emphysema. In this case the resting expiratory 
position is shifted to the inspiration, what may create a circulus vitiosus. 
3.3 Non-allergic or allergic 
Bronchitis is an inflammatory disease of the bronchial mucosa. In most cases the 
inflammation is caused by an infection. Also allergens may cause an acute or chronic 
bronchitis, they act mostly as a trigger. The presence of one or more allergies increases the 
statistical risk for the development of bronchial asthma. Relevant inhalation allergens are 
dust mites, animal dander, mould fungus and pollen. 
As their zoological name "Dermatophagoides" indicates, dust mites feed on epithelia from 
the skin, of which one person loses about 1.5 grams per day. They are, depending on the 
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type, 0.1 - 0.5 mm in size and they live in normal house dust. They are found in carpets, 
curtains, upholstered furniture, mattresses, duvets and pillows, stuffed animals etc. The 
allergen comes from the faeces of the mites. In order to avoid exposure, the following 
protections should be carried out: the use of an encasing such as a mattress cover, monthly 
washing of duvets and pillows, occasional freezing of soft toys at -20 °C, followed by 
rinsing, no long carpets, regular vacuuming and avoidance of dust turbulence. 
With regard to animal dander, those species which are most relevant and which human 
beings have close contact with are especially dogs, cats, guinea pigs, hamsters, horses and 
birds. The allergen concentration varies within a species, depending on the breed. For this 
reason it could happen that someone tolerates contact with one cat very well, whereas 
contact with another cat induces an acute bronchial obstruction. In the case of a clinically 
relevant allergy against an animal, the contact should be avoided. 
The spores of mould fungus can also cause an allergic reaction, like bronchial 
hyperreactivity or bronchial obstruction. If at home the walls are infested with mould 
fungus, the house has to be renovated. 
Among the pollen, early flowering plants (birch, alder, hazel, willow) and grasses are most 
relevant. The occurrence of pollen-induced disorders, namely rhinoconjunctivitis and 
bronchial asthma, are strongly season-dependent and time-limited. On the basis of cross-
reactions, for example between birch pollen and apple, in the case of an allergy against birch 
pollen, an allergic reaction against apple in the form of an oral allergy syndrome may occur. 
In the case of pollen, allergen avoidance is almost impossible. In order to reduce the 
intensity of pollen-induced allergy symptoms, desensitization  is recommended. 
3.4 Special forms: Bronchitis fibroplastica, bronchioloitis obliterans 
A special form of bronchitis in childhood is the bronchitis fibroplastica. Older synonyms are 
fibrinous bronchitis, pseudomembranous bronchitis or Hoffmann’s bronchitis. It is 
characterized by obstruction of the bronchi, usually a lobe or segment, consisting of mucin, 
which forms large endobronchial casts of rubber-like consistency. Pre-existing pathological 
conditions, such as bronchial asthma or cystic fibrosis, which are attended by hypersecretion 
of viscous mucus, may act as triggers. Childhood tuberculosis or primary immunodeficiency 
seem to be associated with a higher incidence of bronchitis fibroplastica as well. However, 
exact epidemiological data are still missing. Main symptoms are a cough and dyspnoea, and 
sometimes pleuritic pain and fever occur. In pulmonary auscultation over the affected area 
of the lung the breath is quiet or absent; sometimes wheezing or rales can be heard. X-rays 
of the chest typically show an atelectatic area next to an emphysematic one. The therapy 
consists in the prompt removal of the sticky casts consisting of mucin via rigid 
bronchoscopy. If they are not removable, administration of N-acetylcysteine or DNase may 
be helpful. If a child without known pre-existing diseases falls ill with bronchitis fibro-
plastica, additional diagnostic investigations should be carried out: sweat tests, tuberculin 
tests, allergy tests. 
Another special form of bronchitis in children is the bronchiolitis obliterans. An inflammation 
of the small airways induces a pathologic tissue remodelling with granulations, which obstruct 
the lumen of the bronchioles. This process may be triggered by infections, inhalation of toxic 
agents, autoimmune diseases or a chronic rejection after lung transplantation. In the group of 
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long-term survivors after lung transplantation, bronchioltis obliterans is the most frequent 
cause of death. The clinical signs and symptoms are quite unspecific: a cough and reduced 
general condition. In pulmonary auscultation the breath is quiet and rales can be heard. The X-
ray of the chest eventually shows some infiltration or it looks normal. The disease may begin 
rapidly or slowly and the clinical course may be progressive or stable. Therapeutic options are 
a high-dose glucocorticoid administration, and in the case of lung transplantation, an increase 
in the dosage of the immunosuppressive medication. 
4. Different stages of bronchitis in children 
4.1 Bronchial hyperreactivity 
Bronchial hyperreactivity is a chronic inflammation of the bronchial mucosa with recurrent 
bronchial obstruction, which may be triggered by infections, allergens or nonspecific 
stimuli, such as cold air, physical or even emotional stress. The inflammatory activity causes 
a swelling of the bronchial mucosa with a reduction of the bronchial lumen consecutively. 
The smaller the lumens are physiologically, such as in infants, the more relevant is its 
reduction regarding clinical symptoms. Furthermore, inflammation of the bronchial mucosa 
increases the vulnerability to viruses or bacteria. 
To make the diagnosis “bronchial hyperreactivity”, an accurate and detailed medical history 
is the most important step. Additionally, measurement of the lung function may confirm the 
diagnosis, in particular in the case of a reduced flow in the smaller airways; after 
administration of a beta-sympathomimetic via inhalation the bronchial obstruction should 
be reversible, at least partly. The lung function test can be carried out with children who are 
old enough to participate actively. Furthermore, measurement of the NO-exhalation may be 
useful to monitor the amount of bronchial inflammation. In some cases it may be helpful to 
carry out a bronchial provocation test via inhalation of methacholine, histamine or 
carbachol. Of course, all emergency tools have to be available. 
4.2 Bronchitis 
Bronchitis is a clinically apparent inflammation of the bronchi, triggered by a bronchial 
hyprerreactivity, by viruses or bacteria or by allergens. The symptoms (cough, tachypnoea 
and dyspnoea, pain, fever), the different courses (acute, complicated, chronic, recurrent) and 
different forms (non-obstructive, obstructive) have been described. 
4.3 Bronchiolitis 
Bronchiolitis is an inflammation of the smallest bronchi and bronchioles. Due to the small 
lumens of these airways, swelling of bronchial mucosa may induce severe obstruction quite 
rapidly, in most cases associated with pulmonary hyperinflation. This can lead to the 
phenomenon of the so-called silent obstruction, that means barely wheezing, humming or 
whistling, but fine bubble rales at the end of inspiration. Bronchiolitis is a typical disease of 
infancy, the age peak is between 4 and 6 months. 
4.4 Bronchopneumonia 
Bronchopneumonia is a possible course of a complicated bronchitis. Whereas a primary 
pneumonia normally is localized to one segment or lobe of the lung, in the case of a 
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bronchopneumonia there is a disseminated inflammation from the bronchi down to the 
alveoli. 
4.5 Bronchial asthma 
Bronchial asthma is a disease with chronic inflammation of the respiratory system with 
bronchial hyperreactivity and variable airway obstructions. In many children and 
adolescents we find a positive family history for asthma and/or allergies. The restriction of 
the air flow, mainly during the expiration, is caused by spastic contraction of the smooth 
muscle in the bronchial wall, oedematous swelling of the bronchial mucosa and 
hypersecretion of viscous mucus. In addition to these pathological mechanisms, a tissue 
remodelling may take place after bronchial asthma over several years, which makes the 
airways less elastic. In most cases patients have an allergic bronchial asthma; case of non-
allergic asthma and mixed forms are possible as well. 
Criteria for the diagnosis of bronchial asthma in children and adolescents are a relative 
forced ventilation capacity (FEV1/VK) < 75% of age- and gender-related norm and a 15 % 
increase with prolonged expiratory time, or after inhalation of a short-acting beta-
sympathomimetic. A further criterion is a decrease in respiratory resistance (R) > 50% of 
baseline after inhalation of a short-acting beta-sympathomimetic. If the lung function 
measurement shows a normal result, but the clinical history is typically for bronchial 
asthma, then a circadian variability of the measured peak expiratory flow (PEF) > 20% 
confirms the diagnosis. If the doctor is still in doubt with the diagnosis, a provocation test 
(for example physical stress or inhalation of metacholine) may be helpful to make the right 
diagnosis. 
The therapy of bronchial asthma is successful if clinical signs and symptoms of the disease 
are under control, so that the affected children or adolescents feel free from disorders if they 
are able to partake in sport without any restriction, if there are no side effects of the 
medications and if no long-term injury will occur. Taken together, if the children or 
adolescents just have a normal life with this chronic disease. Parts of the therapy are 
prevention (for example not smoking, either actively or passively, avoidance of allergens, if 
possible), general procedures (for example participation on training courses of instruction, 
doing sports, doing physiotherapy), pharmacotherapy and rehabilitation, if it is required. 
The prescription of drugs should be carried out in accordance with an algorithm, which has 
various steps depending on the severity of the bronchial asthma and gives the opportunity 
to step up or step down. Standard drugs in pharmacotherapy of bronchial asthma are low-
dose inhaled glucocorticoids and orally administered leukotriene antagonists (additionally 
or alternatively) for long-term therapy, as well as inhaled short-acting beta-sympatho-
mimetics for acute therapy. Because of this treatment, severe asthma attacks have become 
very rare incidents. 
5. Common viruses causing bronchitis in children 
Acute bronchitis is almost (in approximately 90%) induced by viruses. The most common 
ones are respiratory syncytial, parainfluenza-, influenza-, adeno-, rhino-, metapneumo- and 
human bocavirus. Acute bronchitis, which is induced by bacteria primary, is rare (approxi-
mately 10%).  In 15% of viral bronchitis a secondary bacterial  infection will happen. 
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5.1 Respiratory syncytial virus (RSV) 
It is a member of the family of paramyxoviridae, has a single-stranded RNA and is 
enveloped. We distinguish two serological groups A and B from each other. The 
pathogenicity of the virus depends crucially on two glycoproteins on the viral surface: 
glycoprotein G enables the docking with the host cell, such as pneumocytes, glycoprotein F 
is responsible for the endocytosis into the cell. The fact that the affected cell undergoes a 
fusion with neighbouring cells and form syncytia has given the virus its name. Further 
details of incubation time, infection and clinical signs and symptoms are in the section 
"Characteristics of RSV infection." 
5.2 Parainfluenzavirus 
It belongs to the family of paramyxoviridae, has a single-stranded RNA and an envelope. It 
is (in contrast to the influenza viruses) genetically stable. There are 4 different types. The 
transmission of the virus proceeds via droplet or smear infection. The incubation period is 
3 - 6 days. At the age of 2 years, almost all children have been sick at least once with a 
parainfluenza infection. In infancy and early childhood parainfluenza virus causes an acute 
laryngotracheobronchitis with typical croup symptoms. 
5.3 Influenzavirus 
It is assigned to the family of orthomyxoviridae. It is divided into the 3 types A, B and C, of 
which A and B are most relevant for infections of humans. The genome of influenza viruses 
type A and B consists of eight single-stranded RNA segments. This creates a high genetic 
variability of antigenic drift and antigenic shift, in the case of a dual infection.  The eight 
RNA segments contain the genetic information for 11 proteins, of which one is the 
neuraminidase. Transmission paths of the virus are aerosols and saliva, as well as contact 
with contaminated surfaces. The incubation period is 1 - 4 days. Typically we see a high 
incidence of influenza during the winter months. The epidemic often has its origin in the 
nursery, kindergarten or school. Because of the high contagiosity, pandemics with high 
lethality may occur, recently caused by the H1N1 subtype, the so-called "swine flu". In 
contrast to the common cold, the clinical course of the influenza infection is characterized by 
significantly reduced general condition, high fever and a much higher complication rate. 
Children with a disease of the respiratory tract, a heart failure or a deficiency of the immune 
system have an especially high risk for severe complications. The diagnosis of influenza can 
be made with a rapid test (usually an Elisa) or by RT-PCR, which is more sensitive and 
specific, from a nasal or throat swab or corresponding rinse water. 
In the case of a severe or complicated clinical course, treatment with an antiviral compound 
is indicated. In childhood, the neuraminidase inhibitors oseltamivir (oral administration, 
approved from the first year of life) and zanamivir (inhalation, approved from the fifth year 
of life) are used. Safety studies were carried out in order to extend the approval of 
oseltamivir on the first year of life. The vaccination against influenza provides the best 
protection. Because of the high genetic variability of the virus, the vaccination has to be 
repeated each year with a current antigen mixture. In addition to the self-protection, the 
collective protection is of great importance. 
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5.4 Adenovirus 
It is a member of the family of adenoviridae. It is a double-stranded DNA virus with a 
strong environmental resistance. More than 50 serotypes with various clinical manifesta-
tions have been identified so far. The transmission proceeds via droplet or smear infection. 
The incubation time is between 2 and 10 days. Most adenovirus-induced diseases occur in 
the age between 6 months and 5 years, usually in the form of a common cold. However, it 
can lead to complicated clinical courses with severe obstruction, pneumonia or persistent 
bronchial hyperreactivity for months. 
5.5 Rhinovirus 
It belongs to the family of picornaviridae, the RNA is single stranded. We know about 
100 subtypes; the genetic variability is large. Rhinovirus is transmitted primarily via aerosol. 
The incubation period is 2 - 5 days. In the first years of life, the incidence of infection with 
the virus is around 1 - 2 times per year. Whereas in adults rhinovirus infections usually 
cause a common cold, in infants and small children obstructive bronchitis appear quite 
often. 
5.6 Metapneumovirus 
It is a member of the paramyxoviridae, a RNA virus and enveloped. We know 2 subtypes 
A and B, each with two sub-groups A1 and A2, as well as B1 and B2. Droplet and smear 
infections are the transmission paths. Incubation time is 4 – 6 days. During the first year of 
life about one quarter of infants become infected with the metapneumovirus; by the time 
children start school, almost everyone has had an infection with this ubiquitous virus. Most 
prevalent symptoms are rhinitis and bronchitis. 
5.7 Human bocavirus 
The human bocavirus was discovered only in 2005. It belongs to the Parvoviridae family 
and has a single-stranded DNA. The transmission of the virus proceeds via droplet or smear 
infection. Accurate epidemiological data are yet to be collected. Clinically, acute respiratory 
symptoms are most relevant. 
6. Characteristics of RSV infection in children 
6.1 Risk factors 
An RSV infection, which occurs in infancy, may have a severe clinical course. Not only in 
infancy, but until the age of 5 years, RSV infection may cause disorders of clinical relevance. 
The majority of children undergo one or more RSV infections during the first 2 years of life, 
usually without a severe or complicated course. Risk factors for a severe or complicated 
clinical course are small, narrow airways (this is the reason why infants suffer worse than 
older children). Boys are affected slightly more often than girls. Another risk factor, which 
should not be underestimated, is the exposure to tobacco smoke. Furthermore, the family 
history to allergies has an adverse influence. Pre-term birth or chronic diseases of the lung 
increase the risk for a complicated course of a RSV infection considerably. We see a seasonal 
accumulation with endemic-like clusters of RSV infections during the cold autumn and 
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winter months. The transmission occurs by droplet and smear infection. The incubation time 
is at 3 - 6 days. 
6.2 Severity of the clinical course 
If the RS virus affects the respiratory epithelium of the smallest bronchi and bronchioles 
with desquamation of the epithelial cells and oedema of the mucosa, the main symptom is 
bronchial obstruction. Distal to an obstructed airway, atelectatic areas may be formed, next 
to emphysematic areas. If this causes a mismatch between ventilation and perfusion, the 
main symptom is tachydyspnoea with partial or even global respiratory insufficiency. In 
this case, the infant needs to get hospitalized for oxygen substitution and, if necessary, with 
respiratory support or even mechanical ventilation. An additional reason for hospitalization 
is the risk, especially in very young infants, of apnoea and death due to apnoea. 
6.3 Diagnosis 
The diagnosis can be carried out using a rapid test, which is based on the 
immunofluorescence method. The inflammation parameters in the blood are only slightly 
increased. The X-ray of the chest often shows diffuse infiltrations of the lung and a partial 
reduction of the transmission due to emphysema. 
6.4 Limitation of therapeutic options 
The therapeutic options are very limited. Because the replication of the RS virus takes place 
inside the epithelial cells of the lung, bronchodilatatory agents show no positive effect. 
Treatment with steroids has no effect as well, what is confirmed by meta-analysis. An 
antiviral therapy with the nucleoside analogue ribavirin is not recommended for the 
following reasons: firstly, there seems to be no relevant effect; secondly, it is teratogenic and 
has to be administered via aerosol, which could lead to an exposure of pregnant women 
who are in contact to the child. There is only one agent with a small, but significant benefit 
in the case of an RSV bronchitis or bronchiolitis; it is the leukotriene receptor antagonist 
montelukast. Additionally, supportive therapy, such as inhalation with 0.9% NaCl or 
decongestant nose drops may be helpful. 
6.5 Indications for palivizumab 
Palivizumab is a monoclonal antibody against the RS virus. It can be used for passive 
immunization. It binds to the glycoprotein F, the fusion protein, and thereby prevents the 
virus entering the cell. During the months with high incidence of RSV infections, 
palivizumab has to be injected every 4 weeks. Palivizumab is indicated for significant 
prematurity, bronchopulmonary dysplasia and hemodynamic relevant congenital heart 
failures. The prophylactic immunization with palivizumab reduces severity and duration of 
the disease significantly; the hospitalization frequency is halved. 
6.6 Recent research on an active immunization 
Previous research on an active vaccine, already carried out in the 1960s, was not successful. 
Currently there are new research activities in this area. A life vaccine against RSV and PIV3 
(parainfluenza virus type 3) is in phase 1 / 2 study. 
www.intechopen.com
 
Lung Diseases – Selected State of the Art Reviews 452 
7. Bronchopulmonary dysplasia as a risk factor for bronchitis in children 
7.1 Definition and pathophysiology 
Today bronchopulmonary dysplasia (BPD) is more relevant than ever. Because of the major 
advances in neonatology with high survival rates of extremely immature preterm infants, 
there is an increase of diseases and complications, which are typically associated with 
prematurity, like BPD. If very preterm infants are born, their lungs are not completely 
developed, neither structurally nor functionally, especially with respect to the synthesis of 
surfactant. Because of the respiration prior to maturity, the lung tissue undergoes a fibrotic 
remodelling process of the alveoli. Prenatal and postnatal factors, such as inflammation, 
infection, hyperoxia and mechanical ventilation, have an additional adverse effect. 
Because the morphological alterations are not visible and the radiological ones do not 
correlate well with the clinical severity, the BPD is defined by the duration of oxygen 
supplementation for longer than 28 days. Depending on the amount of oxygen supplemen-
tation and the requirement of breathing support, we distinguish mild, moderate and severe 
BPD. 
7.2 Prophylaxis and therapy 
The following prophylactic procedures may reduce the severity of BPD: the prenatal anti-
inflammatory treatment via administration of beta-dexamethasone to the mother, the so-
called “lung maturation”, is standard. The application of surfactant as soon as possible is 
very important. A patent ductus arteriosus with hemodynamic relevance should be treated 
early, if possible pharmacologically, if necessary via ligature. A protective effect of vitamin 
A has been demonstrated, although the effect is only minor. 
Therapeutic procedures are avoidance of hyperoxia, moderate infusion or even forced 
diuresis. high-caloric nutrition, gentle ventilation mode, physiotherapy, and in very rare 
cases, the postnatal application of corticosteroids. 
7.3 Prognosis 
The BPD also affects the future life of the children: they suffer more frequently with 
bronchial hyperreactivity and asthma, they have an increased risk for the incidence of 
respiratory infections, and in the first year of life they are more often hospitalized for acute 
respiratory problems. Even if they have no symptoms, the measurement of lung function 
will show worse values. 
8. Differential diagnoses of bronchitis in children 
8.1 Croup 
In distinction from the original diphtheritic croup (which has become very rare thanks to the 
vaccination), the common croup is a subglottic laryngitis with an inflammatory oedema of 
the mucosa in the context of a viral infection of the respiratory system. The main prevalence 
is at the age between 6 months and 6 years. Typically in the late evening or during the night 
in the cold winter, the affected infants and children get an acute attack with a barking 
cough, hoarseness, inspiratory stridor and dyspnoea. We divide the croup into 4 different 
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degrees of severity, from just cough and hoarseness without dyspnoea to dramatic 
dyspnoea with the feeling of combustion. 
What are the urgent measures in the case of a croup attack? The first step is to reassure the 
anxious and excited child. It should be kept in an upright position, in order to allow the use 
of the thoracal muscles for breathing. The child should be brought into the fresh and cold 
air, which may reduce the swelling of the respiratory mucosa. If available, a glucocorticoid 
suppository can be administered by the parents. Prophylactically, a moistening of the air 
indoors is recommended. In many cases of a moderate croup episode, these easy measures 
may stabilize the situation, that the parents are able to manage it at home without any 
professional help. However, in severe cases or in any cases of doubt, the ambulance should 
be called immediately. The emergency doctor can initiate an inhalation with adrenaline, an 
oxygen supplementation and an intravenous application of a glucocorticoid. If necessary, 
the child can be hospitalized and monitored via pulse oximetry. In very rare cases, the 
sedation of a child (for example with chloral hydrate) is unavoidable. In extreme severe and 
complicated clinical courses, the treatment of the child at an intensive care unit is 
recommended.  
In the extremely rare case of a diphtheritic croup, the treatment with diphtheria antitoxin 
has to start immediately. Also extremely rare (thanks to the haemophilus vaccination), a 
bacterial epiglottitis occurs. But because of its rarity, the risk of misinterpretation as a 
normal croup is quite high. In contrast to the croup, the epiglottitis usually is associated 
with high fever, a very poor general condition, a septic clinical course, an increased 
salivation and dysphagia. An epiglottis is always a peracute emergency.  Inspection of the 
pharynx using a spatula is strictly contraindicated, because the slightest mechanical 
provocation can induce a complete occlusion of the epiglottis without any possibility for an 
intubation. Then only cricothyrotomy or tracheostomy can be carried out, to save the life of 
the child. 
8.2 Aspiration 
Aspiration of gastric juice or of a foreign body causes coughing. Common foreign bodies are 
small pieces of an apple or a carrot, half or whole peanuts and all sorts of small parts made 
of plastic or metal, quite often from the toys, the child has played with. We distinguish 
between the acute and the chronic foreign body aspiration. 
In the case of an acute aspiration the child has an abrupt coughing attack and dyspnoea. 
Because the beginning of the right main bronchus from the trachea is angulated to a lesser 
extent compared with the left one, it is preferentially affected. Over the affected side the 
breath is quiet and wheezing can be heard. Radiologically, a mediastinal shift to the healthy 
side can be seen. 
In contrast to an acute aspiration, which is associated with an abrupt coughing attack and 
dyspnoea, in the case of a chronic aspiration the clinical symptoms are milder and less 
severe. In most cases the foreign body is smaller compared to those of an acute aspiration, so 
that it can slide into a segmental bronchus, settle there and maintain an inflammatory 
response, which occurs as a chronic cough. This is the reason why chronic aspirations quite 
often get misinterpreted as a chronic bronchitis of infectious or allergic origin. 
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For treatment the bronchoscopical removal of the foreign body is necessary, almost always 
in the form of a rigid bronchoscopy. 
8.3 Tuberculosis 
In the case of a chronic cough it is important to take the possibility of a pulmonary 
tuberculosis as a differential diagnosis into account, especially in children who come from 
high-incidence countries, or if they have had or still have close contact with people coming 
from such areas. The mycobacterium tuberculosis is transmitted via the aerosols, which 
comes from coughing people with an open pulmonary tuberculosis. Children are generally 
less contagious, even if they have an open pulmonary tuberculosis, because there are only a 
few bacteria in the sputum. This phenomenon is called paucibacillary tuberculosis. 
At the slightest suspicion of a tuberculosis infection, an appropriate diagnostic investigation 
has to be made: next to an accurate medical history and physical examination, 
immunological tests have to be carried out. These are an intracutanously applied tuberculin 
test and an IGRA (interferon-gamma release assay) from the blood. The combination of both 
tests results in an optimal specifity. Additionally, an X-ray from the chest at two levels 
belongs to the standard diagnostic. The microscopical and microbiological analysis is made 
from induced sputum or from gastric juice, because children younger than 10 years usually 
are not able to give sputum spontaneously. 
If, in the case of an exposure to tuberculosis, all diagnostic investigations have a negative 
result, a chemoprophylaxis with isoniazid for 3 months is recommended. If the 
immunological tests are positive, but the clinical course, the X-ray and the analysis of 
induced sputum or gastric juice show normal results, then a preventive chemotherapy with 
either isoniazid as monotherapy for 9 months or alternatively with isoniazid and rifampicin 
as dual therapy for 4 months should be carried out. If a child has signs or symptoms of a 
tuberculosis, if pulmonary or extra-pulmonary, a combination therapy with at least 3 tuber-
culostatic drugs has to be initiated, for example with isoniazid, rifampicin and 
pyrazinamide. In most cases, after 2 months of treatment the medication can be reduced to 
an isoniazid/rifampicin - dual therapy. The total duration of the treatment depends on the 
clinical course and the severity of complication and is at least 6 months. Of course the choice 
of the tuberculostatic drugs has to be adjusted to possible resistances. 
8.4 Cystic fibrosis (CF) 
If infants have recurrent obstructive bronchitis with a chronic cough and problems to 
dissolve the mucus, one differential diagnosis, which has to be taken into account, is CF. 
Even though it is a rare disease, it is still one of the most common hereditary diseases. The 
mode of inheritance is autosomal recessive and caused by a mutation in the CFTR (cystic 
fibrosis transmembrane conductance regulator) - gene, which encodes a chloride ion 
channel. More than 1500 mutations have been known. The mutation deltaF508 describes the 
deletion of 3 base pairs, what causes the lack of phenylalanine at position 508 of the protein 
chain, and is with 70% by far the most frequent one. Depending on the amount of the CFTR 
defect, there are milder and more severe clinical courses of the disease. Due to the 
dysfunction of the chloride ion channel, the epithelial fluid film becomes hyperosmolar and 
the produced mucus gets dyscrinic. 
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The clinical course is characterized by this problem. Shortly after birth, due to the viscous 
intestinal secretion, a meconium ileus can be the first complication of a CF. The same 
problem may occur in later life as distal intestinal obstruction syndrome (DIOS). The most 
important focus in the progress of the CF is the respiratory system. The viscous sputum 
cannot be mobilized and brought out adequately, what gives bacteria a good medium for 
colonization, unfortunately quite often with mucoid pseudomonas aeruginosa and other 
multi-resistant bacteria. Also pulmonary mycoses (for example an aspergillosis) may occur. 
These permanent inflammatory processes lead to an irreversible tissue remodelling of the 
respiratory tract. At the end, atelectatic areaes and emphysematic bullae, insufficient for 
ventilation or diffusion, replace the normal tissue. Haemoptysis and pneumothoraces are 
dreaded complications. About 90% of all patients with CF develop an exocrine pancreatic 
insufficiency with the consequence of an inadequate intestinal absorption of proteins, fats 
and fat-soluble vitamins, which leads to dystrophy of the affected patients. With further 
progress of the disease, an endocrine pancreatic insufficiency may occur, which is why 
about 15% of all patients with CF develop an insulin-dependent diabetes mellitus. 
Therapeutical tools are the removal of bronchial secretions by autogenic drainage, 
physiotherapy, inhalations, mucolysis and ample fluid intake, the antibacterial treatment by 
intravenous antibiotics, the stimulation of the digestion by dietary fibre enriched food and 
physical activity, the improvement of the intestinal absorption by replacement of enzymes 
(porcine pancreas powder) and substitution of vitamins, and the counteraction of dystrophy 
by high-caloric nutrition. 
In the most patients with CF, the life limiting factor is the global respiratory insufficiency. 
Often, lung transplantation is the only life-prolonging option. Because of the enormous 
medical progress, especially in the development of new antibiotics, the life expectancy of 
people with CF increases steadily and rapidly. CF as a disease which occurs exclusively in 
childhood is part of medical history. 
8.5 Primary ciliary dyskinesis 
A primary ciliary dyskinesis often causes recurrent bronchitis. It is a genetically determined 
(usually autosomal recessive) disorder of the respiratory ciliated epithelium and other 
ciliated cells, resulting in a reduction in mucociliary clearance. Typical clinical symptoms are 
chronic rhinitis and sinusitis with much secretion, chronic bronchitis with a productive 
cough and recurrent pneumonia. Additional possible abnormalities are the formation of a 
hydrocephalus (due to the lack of ciliary motility of the ependymal cells), infertility in male 
(due to the lack of motility of the sperms) and in female patients (due to the lack of motility 
of the cilia of the fallopian tube) or a situs inversus (due to the absence of a directed cilia 
beat during the embryogenesis). A situs inversus occurs in 50% of the patients who are 
affected by the primary ciliary dyskinesis and it is called Kartagener's syndrome. In the 
diagnostic investigation of the primary ciliary dyskinesis the measurement of exhaled NO 
and the analysis of the ciliary function using a light microscope are purposeful tools. For 
confirmation of the diagnosis, an analysis via an electron microscope is needed. Therapeutic 
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8.6 Vocal cord dysfunction 
The vocal cord dysfunction (VCD) is a functional disorder with an acute spasm of the vocal 
cords. In most cases school children are affected. A VCD attack can range from a mild 
dyspnoea to the feeling of suffocation. Fortunately, such episodes are not life threatening, 
because despite the vocal cord spasm a small air gap still remains. Possible triggers for a 
VCD attack are coughing, physical exertion, inhalation of cigarette smoke or reflux of gastric 
juice, postnasal drip syndrome and general stress. 
8.7 Gastroesophageal reflux 
In the case of a recurrent or chronic cough, of course at first everybody thinks of a disease of 
the respiratory system. However, a gastroesophageal reflux may also cause such symptoms. 
Especially in the first months of life, chyme and gastric juice can flow back into the 
oesophagus and induce an inflammation of the mucosa there. Clinical symptoms may be 
heartburn, regurgitation, vomiting, feeding problems and finally dystrophia. Further 
symptoms may be a cough, hoarseness, bronchial obstruction, episodes with apnoea and 
cyanosis, as well as pneumonia due to aspiration. In order to avoid the gastroesophageal 
reflux in infants, the nutrition can be thickened and the feeding portions can be reduced by 
increasing the feeding frequency. In addition, the upper body should be slightly elevated. 
Potential drugs are antacids or proton pump blockers. 
9. Inflammation parameters in the case of bronchitis in children 
9.1 C-reactive protein (CRP) 
CRP is an annular pentamer with sub-units composed of 206 amino acids each. It is 
synthesized in the liver and then secreted into the blood. Its concentration in the blood 
increases within 6 to 48 h in the case of any systemic inflammation. That can be an infectious 
disease, an immune reaction of non-infectious etiology or large tissue damage. Thus, CRP is 
an unspecific marker for inflammation and its increase starts with delay. Depending on the 
laboratory, a plasma concentration up to 0.1 - 1 mg/dl is in the normal range. 
Concentrations between 1 – 10 mg/dl are typical for mild to moderate concentrations,  
> 10 mg/dl for severe inflammation. Because of the reasonably long half-life of 
approximately 24 h, CRP is ideal for the follow-up monitoring of an inflammatory process 
which can help to evaluate the effectiveness of a treatment. 
9.2 Interleukin-6 (IL-6) 
IL-6 is a proinflammatory cytokine consisting of 184 amino acids. It is released primarily by 
monocytes, but also by T-lymphocytes, as well as endothelial and epithelial cells. Infections, 
non-infectious immunological reactions, tissue hypoxia and trauma induce the release of 
IL-6 within 6 h. Thus, IL-6 is an unspecific marker for various forms of inflammation as well, 
but its increase starts much faster. Depending on the laboratory, a plasma concentration up 
to 10 – 50 ng/l is in the normal range. The half-life in the blood is just a few minutes. 
Because of this very short half-life, the kinetics shows a narrow peak with the risk of false 
negative results in the case of measurements outside this peak. 
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9.3 Complete blood count (CBC) 
The CBC may also be helpful in the diagnosis of an inflammation. High increases in the 
amount of the leucocytes occur in bacterial infections, but also in other inflammatory 
processes. Like CRP and IL-6, CBC is a non-specific marker of general inflammation. The 
increase of the leucocytes needs several hours and starts a little bit earlier than the increase 
of the CRP level. The standard value of the amount of leucocytes depends on the age of life: 
for adults 4 - 10 / nl, for school children 5 - 15 / nl, for small children 6 - 17,5 / nl and for 
newborns even 9 - 30 / nl are physiological. The differential blood count shows a reactive 
shift to the immature leucocytes, because their reinforced presence in the peripheral blood 
induces an enhanced release of still premature leucocytes from the bone marrow. 
9.4 Erythrocyte sedimentation rate (ESR) 
The ESR is a very non-specific marker for any kind of inflammation. The pathophysiological 
mechanisms, which lead to a higher ESR, are as follows: in the case of an inflammatory 
condition, erythrocytes form aggregates, which have a lower flow resistance compared to 
the sum of each separate erythrocyte. Furthermore, higher concentrations of acute phase 
proteins (like CRP), of fibrinogen or of immunoglobulins in the plasma, increase the ESR. It 
takes several weeks, after an inflammation has taken place, until an increased ESR gets 
normalized again. Standard value for boys or male adolescents is a sedimentation of 15 mm 
during 1 h, for girls or female adolescents 20 mm during 1 h. 
9.5 Procalcitonin (PCT) 
PCT is a protein which is constructed from 116 amino acids. It is produced mainly in the 
parafollicular C cells of the thyroid gland and in various neuroendocrine cells. Under 
physiological conditions, it acts as a prohormone of calcitonin. It is known that the release of 
PCT increases in the case of an infection, which is caused by bacterials, fungi or parasites. In 
this special condition, PCT is secreted predominantly in cells other the thyroid gland, 
including leukocytes, adipocytes, myocytes and hepatocytes. Stimuli for the synthesis of 
PCT in these cells are bacterial endotoxins (lipopolysaccharides = LPS) and cytokines 
(Interleukin - 1 beta, tumour necrosis factor - alpha). The pathophysiological significance of 
PCT increase has not yet been clarified. Anyway, there is no effect on the thyroid gland. 
The PCT level in the blood increases within 3 h after stimulation by endotoxins or cytokines. 
The maximum of the PCT level is reached after 8 – 24 h and will be stable for another 24 h. 
Then the PCT amount will decrease again with a quite long half-life of 20 – 24 h. In healthy 
individuals, the physiological PCT level is < 0.5 µg/l. Values from 0.5 to 2.0 µg/l are 
associated with a mild respective moderate systemic infection, values from 2.0 to 10.0 µg/l 
with a severe systemic infection and values > 10.0 µg/l are in the majority of cases a sign of 
a sepsis. The amount of PCT correlates with the severity of the infectious disease and the 
mortality rate. In other very severe diseases, such as multiple trauma, large-scale burning, 
cardiogenic shock or multiple organ failure, the PCT level increases as well. 
PCT remains nearly unaffected in the case of a localized, a viral, an autoimmunological or 
an allergic inflammation. For this reason it is an excellent marker for the rapid 
differentiation between viral and bacterial systemic (= antibiotic-requiring) infections. 
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Furthermore, PCT is well suited for the monitoring of the course of a systemic bacterial 
infection. 
A big advantage of PCT, compared to CRP, CBC and ESR, is its much faster increase, which 
allows a very early detection of a systemic bacterial infection. Moreover, its predictive value 
for prediction of sepsis with 0.93 is much better than that of CRP, which is only 0.68. 
Furthermore, the interference by a therapy with steroids is much lower. One advantage 
compared to IL-6 is the better biological stability with a much longer half-life, what reduces 
the risk of false negative results. Additionally, in contrast to IL-6, autoimmunological 
inflammations do not interfere with PCT. 
The measurement of the PCT level in patients with a febrile infection may be helpful to 
decide whether or not a patient needs an antibiotic treatment. In a clinical study it has been 
shown that by using a simple algorithm, the knowledge of the PCT level could reduce the 
administration of antibiotics from 80% previously to 44%. 
On the one hand one wants to avoid the “treatment” of a viral infection with antibiotics, on 
the other hand one wants to assure the start of a required antibiotic therapy in time. 
Especially newborns and young infants may undergo fulminant clinical courses in the form 
of severe sepsis, for which reason this age group is very critical, and it is not acceptable to 
delay the start of an antibiotic treatment. Generally, it seems to be useful to give the 
measurement of PCT a higher priority than is currently given. 
10. Therapeutic concepts for bronchitis in children - pro and contra 
In general, a bronchitis may be treated symptomatically, because in most cases it is caused 
by an viral infection, and there exists no specific treatment. But the importance of the so-
called household remedies should not be underestimated: an adequate fluid intake and 
inhalation of 0.9% NaCl may help to keep the bronchial mucosa moist and to liquefy the 
mucus. Sage drops may reduce the tussive irritation. The inhalation of essential oils, which 
are suitable for children, may also help to reduce discomfort, but it should be noted that 
there is a small risk of sensitization. In addition, there are a number of drugs (some are 
available in the pharmacy without prescription, some have to be prescribed), which have a 
reasonably proficient efficacy. 
10.1 Sympathomimetic 
For the treatment of an acute bronchial obstruction beta 2 - agonists are used, which have a 
selective effect on the respiratory system, in order to minimize beta 1 – receptor - mediated 
adverse effects on the heart. The binding of the drug to its receptor activates the adenylyl 
cyclase whereby ATP is converted to cAMP. That leads to a relaxation of the smooth 
musculature via a reduction in calcium ion concentration in the cells, and it leads to an 
inhibition of the release of mediators from mast cells. Generally, short-acting beta 2 - 
agonists, such as salbutamol, are used. In most cases salbutamol is applied in the form of 
inhalation, the common dosage is about ½ drop per kg body weight in about 2 ml 0.9% 
NaCl, administered with an ultrasonic nebulizer. Alternatively, especially en route,  
1 – 2 puffs of a spray via a spacer can be used. The frequency of inhalation depends on the 
severity of bronchial obstruction. 3 - 6 applications in 24 hours are an average frequency 
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during an acute obstructive bronchitis, but it can be increased, if necessary. The oral 
administration of salbutamol is possible, but because of a lower efficacy and an increase of 
adverse effects due to a higher intake into the blood this is not recommended as a first 
choice. Common adverse effects are restlessness, heart palpitations and shakiness. These 
symptoms are induced by an increased sympathetic activity and can be reduced by 
reduction of the single dosage or the frequency of administration. In pregnant female 
adolescents, salbutamol can induces tocolysis via the beta 2 - receptor. 
10.2 Anticholinergic 
Anticholinergics inhibit acetylcholine due to competition on the muscarinic acetylcholine 
receptors and antagonize its bronchoconstrictive effect. They were applicated via inhalation. 
In comparison to the sympathomimetics, their effect is weaker and occurs with a delay. 
Ipratropium bromide is used most frequently, usually in addition to a beta 2 - agonist, if the 
sympathomimetic effect is not sufficient. Possible side effects include dry mouth, a bitter 
taste, tachycardia and arterial hypertension. 
10.3 Methylxanthine 
The exact mechanism of action of methylxanthines, such as theophylline, is not fully known. 
Several different mokecularbiological pathways seem to be involved: methylxanthines 
inhibit the phosphodiesterase, increase intracellular cAMP and antagonize effects on the 
adenosine receptors. Due to these mechanisms, methylxanthines have bronchodilatatory 
and anti-inflammatory effects and they stimulate the respiratory centre in the brain stem. 
They are rarely used, mainly as reserve medication for severe asthma - attacks. Theophylline 
is then usually given as a continuous infusion. The side effects can be serious: tachycardia, 
extrasystoles, arterial hypertension, restlessness, insomnia, gastrointestinal disorders or 
increased diuresis. 
10.4 Glucocorticoid 
Glucocorticoids induce the secretion of lipocortin, a glycoprotein which inhibits the 
phospholipase A2 and thereby reduces the release of arachidonic acid. Due to this 
mechanism, the cyclooxygenase pathway produces less prostaglandins and the 
lipoxygenase pathway less leukotrienes. Several cytokines, particularly interleukin-1, 
interleukin-2 and tumour necrosis factor – alpha, are produced in a reduced amount as well. 
In the peripheral blood the number of monocytes is decreased and also their bactericidal 
and chemotactic effects, as well as their migration are reduced. All these changes have a 
non-specific anti-inflammatory effect. Depending on the half-life, glucocorticoids are 
divided into short-acting (for example cortisone and cortisol), medium-acting (for example 
prednisone, prednisolone and methyl prednisolone) and long-acting (for example 
dexamethasone) substances. The systematic administration of glucocorticoids over a short 
time period may be necessary in the case of an acute severe bronchial obstruction. In infants 
and young children the application can be carried out in the form of a suppository, which 
can be done at home by the parents. If a child with an acute severe bronchial obstruction is 
brought into the emergency room, the intravenous application is part of the standard 
therapy. The long-term treatment with a glucocoticoid should be done topically, that is via 
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inhalation. Commonly used corticosteroids for an inhalation therapy are budesonide, 
beclomethasone and fluticasone. The dosages are here in the microgram range; that means, 
they are by a factor of 100 – 1000 lower than the systemically given dosages. Thereby any 
side effects are reduced to a minimum. Parents who are afraid of the possible adverse effects 
of corticoids from long-term treatment should have an informative consultation. If they have 
the relevant knowledge, then their worries should be placated. If there are local side effects , 
for example the development of an oral thrush these can arise after inhalation if the mouth 
is not rinsed with water. 
10.5 Leukotriene antagonist 
Leukotrienes, products of the arachidonic acid metabolism, are synthesized in mast cells, 
macrophages, eosinophils and basophils. They have a very strong bronchoconstrictive effect 
(1000-fold more potent than histamine), induce an oedema of the bronchial mucus via 
increasing the capillary permeability and increase the production of mucus. Additionally, 
leukotrienes have a chemotactic influence on inflammatory cells, especially the eosinophils, 
which sensitizes the nerve fibres occurring in the respiratory tract, resulting in a bronchial 
hyperreactivity. The most common leukotriene antagonist is montelukast. Because its 
structure is similar to the leukotriene D4, it acts as a selective competitor at the receptor 
without the effects mentioned above. Montelukast is used as a long-term anti-inflammatory 
therapy, often in combination with a topical corticosteroid. Montelukast is administered 
orally in the evening. The adverse effects that may occur include headache and abdominal 
pain. 
10.6 Mucolytic 
Mucolytic respective secretolytic drugs are expectorants. In contrast to secretomotoric 
drugs, which increase the activity of the ciliated epithelium, expectorants should cause a 
liquefaction of the bronchial mucus to make it easier to cough it up. Among the mucolytics 
are acetylcysteine, bromhexin and ambroxol. Acetylcysteine cleaves the disulfide bonds of 
the mucopolysaccharides. Furthermore, it has an anti-inflammatory effect due to catching 
free radicals with its reactive SH group. Bromhexin activates enzymes, which cleave the 
molecules of the mucus and stimulate the glandular cells to increase the mucus production, 
reduce the viscosity. Ambroxol is a metabolite of bromhexin. In addition to the effects of 
bromhexin, it stimulates the synthesis of surfacant. Some herbal substances, such as ivy, also 
belong to mucolytic drugs. Generally, the therapeutic significance of all these so-called 
cough syrups should not be overestimated. It is much more important that the children 
drink enough and make inhalations. 
10.7 Antitussive 
Antitussives reduce the cough by acting on the brain stem. Opiates, like codeine, 
dihydrocodeine, hydrocodone or noscapine, are the most common drugs against tussive 
irritation. There are newer substances, such as pentoxiverin, which have the advantage of 
lacking a sedative effect or an addiction potential. Pentoxiverin is an agonist at the sigma 
receptor and also acts antagonistically at the muscarinic M1 receptor. Potential side effects 
are nausea, vomiting and diarrhoea. It is contraindicated in children younger than 2 years 
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because a depressant effect on the respiration cannot be excluded, and in pregnant women 
because there are no sufficient safety data. However, in childhood antitussives, these should 
be prescribed only in rare cases with a non-productive cough. Otherwise, if a productive 
cough is inhibited, the mucus remains in the airways, increasing the risk of secondary 
bacterial infections with bronchopneumonia. 
10.8 Antibiotic 
In the case of a bacterial infection treatment with antibiotics is recommended. The choice of 
the appropriate antibiotic depends on the age of the child, because in different age groups 
there are different spectra of bacteria. After receiving the antibiogram, the antibiotic therapy 
can be specified in accordance to sensitivities and resistances of the bacterium. Between 
community-acquired and nosocomial infections, bacterial spectra differ as well. Sometimes 
it is not possible to distinguish between a viral and a bacterial infection, since the clinical 
course and the blood parameters can be quite similar. In this situation it may be that a child 
will be treated with an antibiotic, although it is just a viral infection with high fever. 
10.9 Oxygen supplementation 
In the case of severe bronchial obstruction with spasms of the bronchial musculature, with 
oedema of the bronchial mucosa and production of viscous secretions, ventilation in the 
airways and diffusion in the alveoli may be disturbed. This can cause a partial (hypoxia, 
normocapnia) or global (hypoxia, hypercapnia) respiratory insufficiency. If the 
transcutanously measured oxygen saturation in the blood is too low, the supplementation of 
oxygen is necessary. Usually the oxygen is supplied via nasal prongs. If small children do 
not tolerate nasal prongs, a mask can be placed in front of the face, especially during sleep. 
In the treatment of premature infants with a respiratory distress syndrome, we have 
different procedures, because there the toxic effect of oxygen on the immature organs has to 
be taken into account. Complications caused by oxygen can be BPD, the retinopathy of 
prematurity and an apoptosis-mediated neurodegeneration. The monitoring of the 
premature infants should contain a capnometric analysis next to the measurement of the 
oxygen saturation. 
10.10 Physiotherapy 
Physiotherapy is required in the case of chronic diseases of the respiratory system (for 
example cystic fibrosis or primary ciliary dyskinesis), but also in the case of acute 
pneumological problems (for example the formation of an atelectasis as a complication of 
pneumonia). The aims of physiotherapy are to attain effective ventilation of all lung sections 
and an effective drainage of secretion. 
10.11 Nasal drops 
0.9% NaCl - nose drops are used to moisten and clean the nasal mucosa. Decongestant nose 
drops (dependent on age 0.25%, 0.5% or 1% xylometazoline) should be given, if the 
eustachian tube is swollen in response to an infection of the upper airways, in order to 
guarantee the ventilation of the middle ear. These nose drops should not be given for longer 
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than 7 days, otherwise they could lead to an irreversible damage of the mucosa. A stuffy 
nose is not a good reason for the application of decongestant nose drops. Depending on the 
age of the child, a nose spray may be used instead of nose drops. 
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